Metastatix, Inc. Commences Phase 1 Clinical Trial of MSX-122 in Cancer Patients
12/5/2007 12:25:55 PM
More...
|
Metastatix, Inc. Granted Investigational New Drug (IND) Application for MSX-122
11/6/2007 12:31:38 PM
More...
|
Metastatix, Inc. Closes $35 Million Series B Financing
10/16/2007 4:25:33 PM
More...
|
Metastatix, Inc. Appoints New President and CEO
10/16/2007 6:23:36 AM
More...
|
Metastatix, Inc. Completes Series A Financing; H.I.G. Ventures Leads $3.6 Million Round For Atlanta-Based Biopharmaceutical Company
9/7/2006 2:43:43 PM
More...
|